Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
AATIC: Ascorbic Acid in CMT1A
NCT00271635Phase 2Completed
- Sponsor
- University of Amsterdam
- Start
- Jan 2006
- Primary completion
- Jul 2007
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in Charcot-Marie-Tooth disease type 1A (CMT1A) comparing Ascorbic acid with Placebo (2 arms). Primary endpoint: Motor nerve conduction velocity of the median nerve at 1 year. Started Jan 2006; status: completed.
02
Drugs
ascorbic acid
03
Conditions
Charcot-Marie-Tooth disease type 1A (CMT1A)
Beyond the preview
Go deeper on NCT00271635.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00271635.